SVB Wealth’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,004
| Closed | -$28.5K | – | 1177 |
|
|
2025
Q1 | $28.5K | Buy |
+1,004
| New | +$28.5K | ﹤0.01% | 678 |
|
|
2024
Q3 | – | Sell |
-2,771
| Closed | -$329K | – | 383 |
|
|
2024
Q2 | $329K | Sell |
2,771
-611
| -18% | -$72.6K | 0.01% | 543 |
|
|
2024
Q1 | $360K | Buy |
3,382
+59
| +2% | +$6.29K | 0.01% | 569 |
|
|
2023
Q4 | $330K | Buy |
+3,323
| New | +$330K | 0.01% | 589 |
|
|
2023
Q2 | – | Sell |
-2,233
| Closed | -$343K | – | 975 |
|
|
2023
Q1 | $343K | Sell |
2,233
-1,519
| -40% | -$233K | ﹤0.01% | 668 |
|
|
2022
Q4 | $674K | Buy |
3,752
+975
| +35% | +$175K | 0.01% | 482 |
|
|
2022
Q3 | $329K | Buy |
2,777
+1,061
| +62% | +$126K | ﹤0.01% | 662 |
|
|
2022
Q2 | $245K | Buy |
1,716
+215
| +14% | +$30.7K | ﹤0.01% | 626 |
|
|
2022
Q1 | $258K | Buy |
1,501
+164
| +12% | +$28.2K | ﹤0.01% | 624 |
|
|
2021
Q4 | $340K | Buy |
1,337
+59
| +5% | +$15K | 0.01% | 544 |
|
|
2021
Q3 | $492K | Buy |
1,278
+189
| +17% | +$72.8K | 0.01% | 601 |
|
|
2021
Q2 | $256K | Sell |
1,089
-445
| -29% | -$105K | ﹤0.01% | 816 |
|
|
2021
Q1 | $201K | Buy |
+1,534
| New | +$201K | ﹤0.01% | 831 |
|